Want to see IN:BANKA full AI Analyst Report?
Top Page
Banka BioLoo Ltd.
(BANKA)
Select Model
Select Model
Rating:41Neutral
Price Target:
₹76.00
▼(-4.04% Downside)
Action:Reiterated
Date:08/28/26
The score is held back primarily by weak financial quality—especially persistently negative operating/free cash flow alongside higher leverage and volatile profitability. Technicals also lean bearish in the near term with the stock trading below key moving averages and negative MACD. Valuation is an additional drag due to the extremely high P/E, which amplifies risk given the company’s inconsistent earnings and cash generation.
Positive Factors
Multi-year Revenue Growth
Sustained revenue expansion indicates continuing demand for the company’s sanitation products and services. If maintained, this growth can improve operating scale and support stronger profitability once execution and cost control become more consistent.
Negative Factors
Persistent Cash Absorption
Repeated negative operating and free cash flow suggests the business is not consistently funding itself through operations. Continued cash absorption can increase reliance on borrowing or external capital and constrain investment in future growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Multi-year Revenue Growth
Sustained revenue expansion indicates continuing demand for the company’s sanitation products and services. If maintained, this growth can improve operating scale and support stronger profitability once execution and cost control become more consistent.
Read all positive factors
Banka BioLoo Ltd. (BANKA) vs. iShares MSCI India ETF (INDA)
Market Cap
₹863.62M
Dividend Yield0.95%
Average Volume (3M)3.47K
Price to Earnings (P/E)265.9
Beta (1Y)1.79
Revenue Growth7.77%
EPS GrowthN/A
CountryIN
Employees818
SectorGeneral
Sector StrengthN/A
IndustryIndustrial - Pollution & Treatment Controls
Share Statistics
EPS (TTM)0.30
Shares Outstanding10,931,932
10 Day Avg. Volume2,578
30 Day Avg. Volume3,473
Financial Highlights & Ratios
PEG Ratio-1.26
Price to Book (P/B)1.30
Price to Sales (P/S)0.90
P/FCF Ratio-6.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Banka BioLoo Ltd. Business Overview & Revenue Model
Company Description
Banka BioLoo Limited is an Indian enterprise offering a comprehensive suite of products and services for sanitation and waste management. A key aspect of its operations involves the design, provision, and deployment of bio-toilets. Beyond installa...
Banka BioLoo Ltd. Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
52
Neutral
Cash Flow
28
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 565.03M | 570.92M | 541.74M | 499.96M | 423.50M | 387.51M |
| Gross Profit | 162.46M | 58.70M | 9.87M | 337.57M | 368.11M | 320.30M |
| EBITDA | 65.32M | 62.25M | -28.60M | 41.85M | 66.06M | 58.91M |
| Net Income | 3.57M | 3.93M | -89.09M | -6.53M | 25.39M | 31.08M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 1.01B | 821.55M | 774.23M | 652.07M | 640.54M |
| Cash, Cash Equivalents and Short-Term Investments | 110.08M | 110.08M | 40.70M | 16.88M | 13.41M | 8.29M |
| Total Debt | 0.00 | 408.03M | 347.28M | 259.13M | 167.15M | 184.96M |
| Total Liabilities | -425.75M | 581.35M | 505.70M | 376.61M | 251.09M | 265.52M |
| Stockholders Equity | 425.75M | 395.55M | 315.13M | 397.20M | 400.99M | 375.02M |
Cash Flow | ||||||
| Free Cash Flow | 11.47M | -82.89M | -69.53M | -72.06M | 9.40M | -36.00M |
| Operating Cash Flow | 42.83M | -22.92M | -24.71M | 27.63M | 73.53M | -4.40M |
| Investing Cash Flow | -5.01M | -24.17M | -63.44M | -100.69M | -57.18M | -27.17M |
| Financing Cash Flow | -39.54M | 146.75M | 87.50M | 67.76M | -33.29M | 9.55M |
Banka BioLoo Ltd. Technical Analysis
Neutral
79.20
Price Trends
86.17
Negative
85.09
Negative
73.62
Positive
Market Momentum
-2.39
Negative
44.95
Neutral
28.29
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BANKA, the sentiment is Neutral. The current price of 79.2 is below the 20-day moving average (MA) of 79.82, below the 50-day MA of 86.17, and above the 200-day MA of 73.62, indicating a neutral trend. The MACD of -2.39 indicates Negative momentum. The RSI at 44.95 is Neutral, neither overbought nor oversold. The STOCH value of 28.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:BANKA.
Banka BioLoo Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | ₹60.05B | 49.42 | ― | 0.31% | 10.15% | -53.64% | |
56 Neutral | ₹1.36B | 9.05 | ― | ― | 2.73% | -18.79% | |
55 Neutral | ₹1.10B | 6.24 | ― | ― | -9.15% | -26.23% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
41 Neutral | ₹863.62M | 265.90 | ― | 0.95% | 7.77% | ― |
* General Sector Average
IN:BANKA
Banka BioLoo Ltd.
79.00
-6.11
-7.18%
IN:BEWLTD
BEW Engineering Ltd.
49.30
-105.85
-68.22%
IN:DUCON
Ducon Infratechnologies Ltd.
1.91
-1.93
-50.23%
IN:IONEXCHANG
Ion Exchange (India) Ltd.
409.45
-6.69
-1.61%
IN:KHFM
KHFM Hospitality & Facility Management Services Ltd.
44.95
-34.55
-43.46%
IN:TEXMOPIPES
Texmo Pipes & Products Ltd.
46.58
-10.16
-17.91%
Banka BioLoo Ltd. Corporate Events
Banka BioLoo Sets Virtual Date for 14th Annual General Meeting
Aug 21, 2026
Banka BioLoo Ltd. has notified the National Stock Exchange of India that its 14th Annual General Meeting will be held on 17 September 2026 at 3:00 p.m. via video conferencing and other audio-visual means. The company has published newspaper advert...
Banka BioLoo Publishes Q1 FY27 Unaudited Results in Line With SEBI Norms
Aug 15, 2026
Banka BioLoo has published its unaudited standalone and consolidated financial results for the quarter ended 30 June 2026 in the Financial Express (English) and Nava Telangana (Telugu), in line with Indian securities listing regulations. The compa...
Banka BioLoo shuts trading window ahead of June-quarter results
Jun 26, 2026
Banka BioLoo Limited has announced the closure of its trading window for directors, designated persons, and their immediate relatives from 1 July 2026, in line with SEBI’s Prohibition of Insider Trading Regulations and the company’s in...
Banka BioLoo Fully Redeems Rs 4.3 Crore in Unlisted Debentures
Jun 25, 2026
Banka BioLoo Ltd. has fully redeemed 430 secured, unrated, unlisted, redeemable, transferable non-convertible debentures with a face value of Rs. 1,00,000 each, totaling Rs. 4.3 crore. The debenture holder issued a No Due Certificate confirming th...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.